PITTSBURGH, July 26 /PRNewswire/ -- Over 250 medical physicists attending the American Association of Physicists in Medicine (AAPM) annual meeting turned out for an Elekta event Sunday evening (July 25). Attendees reviewed advances in image-guided radiation therapy (IGRT) with the Elekta Synergy(TM) Research Group members currently utilizing Elekta Synergy(TM), the most advanced weapon in the fight against cancer.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )
The tremendous interest in this Elekta event stems from the fact that the overwhelming majority of papers on Volumetric Imaging IGRT presented at AAPM are based on clinical experience using Elekta technology. Elekta was the first manufacturer to start research on IGRT, the first to have systems in clinical use, and the first to bring these solutions to market.
Elekta Synergy(TM) is revolutionizing radiation therapy with the first radiation treatment platform with an integrated imaging system. This technology enables doctors to obtain images of patients at the point of treatment, allowing them to visualize tumors at the time of treatment and more precisely target tumors while minimizing damage to surrounding tissue.
"Only Elekta gives clinicians the power to treat their patients with unmatched accuracy," said Jim Rose, Vice President Marketing. "With Elekta Synergy(TM), clinicians can visualize the target at the time and point of treatment, thereby sparing healthy tissue while using a higher dose to achieve optimum results."
Advanced technology that benefits patients and supports a strong business model is one of the key reasons Elekta's solutions are being rapidly adopted nationwide, particularly by healthcare group purchasing organizations (GPOs). Elekta's share of the GPO market has risen dramatically due to the expiration of old contracts and the switch or addition of Elekta to new, multi-year purchasing contracts.
About Elekta Synergy(TM) Research Group (ESRG):
The mission of the ESRG is to further define and expand the role of Image Guided Radiation Therapy. The five centers that make up this prestigious group are Christie Hospital Manchester, UK; The Netherlands Cancer Institute (NKI), AvL Hospital, Amsterdam, The Netherlands; Princess Margaret Hospital Toronto, Canada; William Beaumont Hospital Royal Oak, Michigan, USA; and Thomas Jefferson University Philadelphia, USA.
About Elekta:
Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient.
Photo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGOPRN Photo Desk, photodesk@prnewswire.comElektaCONTACT: Michelle Lee, PR and Advertising Manager, +1-770-670-2447, ormichelle.lee@elekta.com , or Investor inquiries, United States, Lars Jonsteg,VP Investor Relations North America, +1-770-670-2419, orlars.jonsteg@elekta.com , or International, Peter Ejemyr, Group VP CorporateCommunications, +46 8 587 254 00, or peter.ejemyr@elekta.com , all of Elekta
Web site: http://www.elekta.com/
